Nipro Corporation, headquartered in Osaka, Japan, specializes in the development and manufacturing of advanced biomedical devices. The company focuses on innovative solutions in areas such as bone regeneration materials, multilumen catheters, and safety-engineered syringes. Nipro's expertise extends to critical medical technologies, including indwelling needle assemblies, blood purification apparatuses, and hemostasis valves. With a commitment to enhancing patient care, Nipro plays a significant role in the global healthcare landscape through its cutting-edge medical products.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

388 Patents

#53 in Osaka

#447 in Japan

#2,391 in the World

Osaka, Japan

Nipro Corporation

Forward Citations = 5,755

483 inventors:

Yoshihiko Sano (26 out of 30 patents)

Hiroyuki Nakagami (25 out of 29 patents)

Katsuya Miyagawa (24 out of 31 patents)

4. Katsuhiro Hiejima (18 out of 30 patents)

5. Mitsuru Hasegawa (17 out of 17 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Nipro Corporation. Retrieved from https://idiyas.com/company/nipro

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

5 patents (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

204 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]